Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders

Journal of Neuroscience

Volumn 30, Issue 43, 2010, Pages 14482-14489

  Hahn, Andreas ^a   Lanzenberger, Rupert ^a   Wadsak, Wolfgang ^a   Spindelegger, Christoph ^a   Moser, UIrike ^a   Mien, Leonhard Key ^a   Mitterhauser, Markus ^a   Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A AUTORECEPTOR; SEROTONIN 1A HETERORECEPTOR; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AMYGDALOID NUCLEUS; ANXIETY DISORDER; ARTICLE; BRAIN MAPPING; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG DOSE INCREASE; FEMALE; HIPPOCAMPUS; HUMAN; INSULA; MALE; MENTAL PATIENT; ORBITAL CORTEX; PANIC; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PSYCHOPHARMACOTHERAPY; RECEPTOR BINDING; SOCIAL PHOBIA;

ADULT; ALGORITHMS; ANXIETY DISORDERS; AUTORECEPTORS; BRAIN; BRAIN CHEMISTRY; CITALOPRAM; DATA INTERPRETATION, STATISTICAL; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 78049348667     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2409-10.2010     Document Type: Article

References (76)

1. Akimova E, Lanzenberger R, Kasper S (2009) The serotonin-1A receptor in anxiety disorders. Biol Psychiatry 66:627-635.
2. Arango V, Underwood MD, Boldrini M, Tamir H, Kassir SA, Hsiung S-C, Chen JJ-X, Mann JJ (2001) Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 25:892-903. (Pubitemid 34031894)
3. Azmitia EC (1999) Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 21:33S-45S.
4. Banasr M, Hery M, Printemps R, Daszuta A (2004) Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone. Neuropsychopharmacology 29:450-460. (Pubitemid 38365922)
5. Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ (2002) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders. World J Biol Psychiatry 3:171-199.
6. Becherer A (2008) The molecular background of sex differences in depressive disorders: still an enigma. Eur J Nucl Med Mol Imaging 35:2156-2158.
7. Blier P, De Montigny C (1983) Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat. J Neurosci 3:1270-1278. (Pubitemid 13060722)
8. Blier P, de Montigny C (1999) Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 21:91S-98S. (Pubitemid 29396476)
9. Blier P, Pineyro G, el Mansari M, Bergeron R, de Montigny C (1998) Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission. Ann N Y Acad Sci 861:204-216. (Pubitemid 29047718)
10. Borg J, Andree B, Lundberg J, Halldin C, Farde L (2006) Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions - a strategy in translational psychopharmacology. Psychopharmacology 185:389-394.
11. Bosker FJ, Cremers TI, Jongsma ME, Westerink BH, Wikstrom HV, den Boer JA (2001) Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala. J Neurochem 76:1645-1653.
12. Bundgaard C, Larsen F, Jorgensen M, Gabrielsson J (2006) Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels. Eur J Pharm Sci 29:394-404. (Pubitemid 44780972)
13. Burghardt NS, Bush DE, McEwen BS, LeDoux JE (2007) Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist. Biol Psychiatry 62:1111-1118.
14. Cannistraro PA, Rauch SL (2003) Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol Bull 37:8-25.
15. Casanovas JM, Hervas I, Artigas F (1999) Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport 10:1441-1445. (Pubitemid 29354326)
16. Cowen PJ, Clifford EM, Walsh AES, Williams C, Fairburn CG (1996) Moderate dieting causes 5-HT2C receptor supersensitivity. Psychol Med 26:1155-1159. (Pubitemid 26382009)
17. Czesak M, Lemonde S, Peterson EA, Rogaeva A, Albert PR (2006) Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 26:1864-1871. (Pubitemid 43236999)
18. Dawson LA, Nguyen HQ, Smith DI, Schechter LE (2000) Effects of chronic fluoxetine treatment in the presence and absence of (+/-) pindolol: a microdialysis study. Br J Pharmacol 130:797-804.
19. Dranovsky A, Hen R (2006) Hippocampal neurogenesis: regulation by stress and antidepressants. Biol Psychiatry 59:1136-1143.
20. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C (2000) Serotonin type-1A receptor imaging in depression. Nucl Med Biol 27:499-507. (Pubitemid 30658154)
21. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C (2007) Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34:865-877. (Pubitemid 47505401)
22. El Mansari M, Sanchez C, Chouvet G, Renaud B, Haddjeri N (2005) Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30:1269-1277. (Pubitemid 40848081)
23. Evans AK, Reinders N, Ashford KA, Christie IN, Wakerley JB, Lowry CA (2008) Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rates in the midbrain raphe complex. Eur J Pharmacol 590:136-149.
24. Fakra E, Hyde LW, Gorka A, Fisher PM, Munoz KE, Kimak M, Halder I, Ferrell RE, Manuck SB, Hariri AR (2009) Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. Arch Gen Psychiatry 66:33-40.
25. Fink KB, Gothert M (2007) 5-HT receptor regulation of neurotransmitter release. Pharmacol Rev 59:360-417.
26. Fink M, Wadsak W, Savli M, Stein P, Moser U, Hahn A, Mien LK, Kletter K, Mitterhauser M, Kasper S, Lanzenberger R (2009) Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET. Neuroimage 45:598-605.
27. Fisher PM, Meltzer CC, Ziolko SK, Price JC, Moses-Kolko EL, Berga SL, Hariri AR (2006) Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity. Nat Neurosci 9:1362-1363.
28. Frey BN, Rosa-Neto P, Lubarsky S, Diksic M (2008) Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study. Neuroimage 42:850-857.
29. Frodl T, Meisenzahl EM, Zill P, Baghai T, Rujescu D, Leinsinger G, Bottlender R, Schüle C, Zwanzger P, Engel RR, Rupprecht R, Bondy B, Reiser M, Möller HJ (2004) Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. Arch Gen Psychiatry 61:177-183. (Pubitemid 38146553)
30. Gordon JA, Hen R (2004) The serotonergic system and anxiety. Neuromol Med 5:27-40.
31. Gordon JA, Lacefield CO, Kentros CG, Hen R (2005) State-dependent alterations in hippocampal oscillations in serotonin 1A receptor-deficient mice. J Neurosci 25:6509-6519.
32. Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R (2002) Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396-400. (Pubitemid 34272867)
33. Gunn RN, Sargent PA, Bench CJ, Rabiner EA, Osman S, Pike VW, Hume SP, Grasby PM, Lammertsma AA (1998) Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. Neuroimage 8:426-440.
34. Hajos M, Hoffmann WE, Tetko IV, Hyland B, Sharp T, Villa AE (2001) Different tonic regulation of neuronal activity in the rat dorsal raphe and medial prefrontal cortex via 5-HT(1A) receptors. Neurosci Lett 304:129-132. (Pubitemid 32436393)
35. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM (2006) Anti-depressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 59:816-820.
36. Heslop KE, Curzon G (1999) Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes. Neuropharmacology 38:883-891.
37. Hirvonen J, Kajander J, Allonen T, Oikonen V, Nagren K, Hietala J (2007) Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region. J Cereb Blood Flow Metab 27:185-195. (Pubitemid 46006596)
38. Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H, Nagren K, Salminen JK, Hietala J (2008) Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 11:465-476. (Pubitemid 351744802)
39. Hornung JP (2010) The neuroanatomy of the serotonergic system. In: Handbook of the behavioral neurobiology of serotonin (Müller CP, Jacobs BL, eds), pp 51- 64. London: Academic.
40. Howell D (2002) Statistical methods for psychology, Ed 5. Belmont, CA: Duxbury.
41. Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, Suhara T, Suzuki K, Innis RB, Carson RE (2003) Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23:1096-1112. (Pubitemid 37082435)
42. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, et al. (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533-1539. (Pubitemid 47301451)
43. Jovanovic H, Cerin A, Karlsson P, Lundberg J, Halldin C, Nordstrom AL (2006) A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res 148:185-193. (Pubitemid 44750584)
44. Jovanovic H, Lundberg J, Karlsson P, Cerin A, Saijo T, Varrone A, Halldin C, Nordstrom AL (2008) Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage 39:1408-1419.
45. Kasper S, Stein DJ, Loft H, Nil R (2005) Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study. Br J Psychiatry 186:222-226. (Pubitemid 40343816)
46. Klein N, Sacher J, Geiss-Granadia T, Mossaheb N, Attarbaschi T, Lanzenberger R, Spindelegger C, Holik A, Asenbaum S, Dudczak R, Tauscher J, Kasper S (2007) Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study. Psychopharmacology 191:333-339. (Pubitemid 46354624)
47. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158.
48. Lanzenberger RR, Mitterhauser M, Spindelegger C, Wadsak W, Klein N, Mien LK, Holik A, Attarbaschi T, Mossaheb N, Sacher J, Geiss-Granadia T, Kletter K, Kasper S, Tauscher J (2007) Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 61:1081-1089. (Pubitemid 46551966)
49. Le Poul E, Boni C, Hanoun N, Laporte AM, Laaris N, Chauveau J, Hamon M, Lanfumey L (2000) Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39:110-122.
50. Lowry CA, Johnson PL, Hay-Schmidt A, Mikkelsen J, Shekhar A (2005) Modulation of anxiety circuits by serotonergic systems. Stress 8:233-246. (Pubitemid 43163256)
51. Mengod G, Cortés R, Vilaró MT, Hoyer D (2010) Distribution of 5-HT receptors in the central nervous system. In: Handbook of the behavioral neurobiology of serotonin (Müller CP, Jacobs BL, eds), pp 123-138. London: Academic.
52. Meyer JH, Kapur S, Eisfeld B, Brown GM, Houle S, DaSilva J, Wilson AA, Rafi-Tari S, Mayberg HS, Kennedy SH (2001) The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am J Psychiatry 158:78-85. (Pubitemid 32047250)
53. Michelsen KA, Prickaerts J, Steinbusch HW (2008) The dorsal raphe nucleus and serotonin: implications for neuroplasticity linked to major depression and Alzheimer's disease. Prog Brain Res 172:233-264.
54. Monk CS, Telzer EH, Mogg K, Bradley BP, Mai X, Louro HM, Chen G, McClure-Tone EB, Ernst M, Pine DS (2008) Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry 65:568-576. (Pubitemid 351645052)
55. Moulin-Sallanon M, Charnay Y, Ginovart N, Perret P, Lanfumey L, Hamon M, Hen R, Fagret D, Ibanez V, Millet P (2009) Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins. Synapse 63:106-116.
56. Nash JR, Sargent PA, Rabiner EA, Hood SD, Argyropoulos SV, Potokar JP, Grasby PM, Nutt DJ (2008) Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br J Psychiatry 193:229-234.
57. Ögren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P, Meister B, Kehr J, Stiedl O (2008) The role of 5-HT1A receptors in learning and memory. Behav Brain Res 195:54-77.
58. Parsey RV, Arango V, Olvet DM, Oquendo MA, Van Heertum RL, John Mann J (2005) Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J Cereb Blood Flow Metab 25:785-793. (Pubitemid 40905606)
59. Parsons LH, Kerr TM, Tecott LH (2001) 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem 77:607-617.
60. Rabiner EA, Messa C, Sargent PA, Husted-Kjaer K, Montgomery A, Lawrence AD, Bench CJ, Gunn RN, Cowen P, Grasby PM (2002) Adatabase of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables. Neuroimage 15:620-632.
61. Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF, Gardier AM, Dranovsky A, David DJ, Beck SG, Hen R, Leonardo ED (2010) 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65:40-52.
62. Sanchez C, Bergqvist PB, Brennum LT, Gupta S, Hogg S, Larsen A, Wiborg O (2003) Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berl) 167:353-362.
63. Sharp T, Boothman L, Raley J, Queree P (2007) Important messages in the "post": recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci 28:629-636.
64. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA (2001) Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 50:651-658.
65. Sogaard B, Mengel H, Rao N, Larsen F (2005) The pharmacokinetics of escitalopram after oral and intravenous administration of single and multiple doses to healthy subjects. J Clin Pharmacol 45:1400-1406. (Pubitemid 41642443)
66. Spindelegger C, Lanzenberger R, Wadsak W, Mien LK, Stein P, Mitterhauser M, Moser U, Holik A, Pezawas L, Kletter K, Kasper S (2008) Influence of escitalopram treatment on 5-HT(1A) receptor binding in limbic regions in patients with anxiety disorders. Mol Psychiatry 14:1040-1050.
67. Sprouse J, Braselton J, Reynolds L, Clarke T, Rollema H (2001) Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies. Synapse 41:49-57. (Pubitemid 32467479)
68. Steiger JH (1980) Tests for comparing elements of a correlation matrix. Psychol Bull 87:245-251.
69. Stein P, Savli M, Wadsak W, Mitterhauser M, Fink M, Spindelegger C, Mien LK, Moser U, Dudczak R, Kletter K, Kasper S, Lanzenberger R (2008) The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635. Eur J Nucl Med Mol Imaging 35:2159-2168.
70. Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY, Mann JJ, Parsey RV (2009) Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biol Psychiatry 66:223-230.
71. Tork I (1990) Anatomy of the serotonergic system. Ann N Y Acad Sci 600: 9-34, discussion 34-35.
72. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289. (Pubitemid 34852226)
73. Varnas K, Halldin C, Hall H (2004) Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum Brain Mapp 22:246-260. (Pubitemid 38891003)
74. Wadsak W, Mien LK, Ettlinger DE, Lanzenberger R, Haeusler D, Dudczak R, Kletter K, Mitterhauser M (2007) Simple and fully automated preparation of [carbonyl-11C]WAY-100635. Radiochim Acta 95:417-422.
75. Witte AV, Floel A, Stein P, Savli M, Mien LK, Wadsak W, Spindelegger C, Moser U, Fink M, Hahn A, Mitterhauser M, Kletter K, Kasper S, Lanzenberger R (2009) Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum Brain Mapp 30:2558-2570.
76. Wu X, Castren E (2009) Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells. Biol Psychiatry 66:5-8.